Company news
OPKO Health, Inc. news in 2023
OPKO Health, Inc.'s news releases, calls and decks from 2023, newest first.
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
November 27, 2023
OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
November 5, 2023
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
November 1, 2023
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
October 30, 2023
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
October 24, 2023
ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
September 27, 2023
OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
August 2, 2023
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
July 24, 2023
OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results
May 2, 2023
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
April 24, 2023
OPKO Health to Hold Virtual R&D Day on March 20, 2023
March 8, 2023
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
March 7, 2023
OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
February 22, 2023
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
February 15, 2023
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
February 8, 2023
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023